Antibiotic sensitivity pattern for non-beta lactam antibiotics and carbapenems in extended-spectrum beta-lactamase (ESBL) producing uropathogens versus non-ESBL producing uropathogens

<p><strong>Introduction and Objectives:</strong> Urinary tract infections (UTIs) are frequent and predominantly caused by coliforms. ESBL producers are increasing in number limiting therapeutic options. It is therefore vital to institute precise, empiric antibiotic guidelines in or...

Full description

Bibliographic Details
Main Authors: W. R. P. L. I. Wijesooriya, Y. B. Herath, R. A. I. Sugandhi, A. Weerawardhana, D. S. Ediriweera
Format: Article
Language:English
Published: Sri Lankan Society for Microbiology 2017-10-01
Series:Sri Lankan Journal of Infectious Diseases
Subjects:
Online Access:https://sljid.sljol.info/articles/8154
_version_ 1828095362739470336
author W. R. P. L. I. Wijesooriya
Y. B. Herath
R. A. I. Sugandhi
A. Weerawardhana
D. S. Ediriweera
author_facet W. R. P. L. I. Wijesooriya
Y. B. Herath
R. A. I. Sugandhi
A. Weerawardhana
D. S. Ediriweera
author_sort W. R. P. L. I. Wijesooriya
collection DOAJ
description <p><strong>Introduction and Objectives:</strong> Urinary tract infections (UTIs) are frequent and predominantly caused by coliforms. ESBL producers are increasing in number limiting therapeutic options. It is therefore vital to institute precise, empiric antibiotic guidelines in order to prevent life-threatening urosepsis. The objective of this study was to compare antibiotic sensitivity (ABST) pattern of ESBL producers and non-ESBL producers against selected non-beta lactams and carbapenem antibiotics.</p><p> </p><p><strong>Methodology:</strong> Retrospective analysis of ABST of significant urinary coliform isolates was done. <br />Study setting: Department of Medical Microbiology, Faculty of Medicine, University of Kelaniya and Base Hospital, Wathupitiwala, Sri Lanka. <br />Study period: 01.01.2012 - 01.01.2016. <br />Study groups: ESBL producers and non-ESBL producers, 63 in each group. Sensitivity profiles of amikacin, gentamicin, netilmicin, nitrofurantoin, nalidixic acid, norfloxacin, ciprofloxacin, imipenem and meropenem were analyzed. Statistical analysis: R programming language. Level of significance P&lt;0.05.</p><p><strong>Results:</strong> ESBL producers were present in 63 patients, 36 (57.1%) of whom were females and 39 were inpatients (61.9%). Non-ESBL producers were isolated from urine of 63 patients, of whom 49 (77.8%) were females and 17 (26.9%) inpatients. Antibiotic sensitivity of ESBL producers ranged from 82.2% to 100% for netilmicin, amikacin, meropenem and imipenem, 65% for nitrofurantoin and from 14.8% to 32.1% for nalidixic acid, ciprofloxacin, norfloxacin and gentamicin. Antibiotic sensitivity of the non-ESBL producers ranged from 56.7% for nalidixic acid and from 76.8% to 85.1% for ciprofloxacin, nitrofurantoin, norfloxacin and gentamicin.</p><p><strong>Conclusion:</strong> A female predominance was noted in both non ESBL and ESBL producers but there was a significant dominance of ESBL producers in male patients. ESBL producers were significantly common amongst inpatients than outpatients. ESBL-producers had significantly high resistance against nalidixic acid, ciprofloxacin, norfloxacin and gentamicin compared to non-ESBL producers. However, more than 2/3rd of isolates in both groups were sensitive to nitrofurantoin.</p>
first_indexed 2024-04-11T07:12:18Z
format Article
id doaj.art-7f9d0df5af524278b613210c19f73a1b
institution Directory Open Access Journal
issn 2012-8169
2448-9654
language English
last_indexed 2024-04-11T07:12:18Z
publishDate 2017-10-01
publisher Sri Lankan Society for Microbiology
record_format Article
series Sri Lankan Journal of Infectious Diseases
spelling doaj.art-7f9d0df5af524278b613210c19f73a1b2022-12-22T04:38:08ZengSri Lankan Society for MicrobiologySri Lankan Journal of Infectious Diseases2012-81692448-96542017-10-0172929910.4038/sljid.v7i2.81545741Antibiotic sensitivity pattern for non-beta lactam antibiotics and carbapenems in extended-spectrum beta-lactamase (ESBL) producing uropathogens versus non-ESBL producing uropathogensW. R. P. L. I. Wijesooriya0Y. B. Herath1R. A. I. Sugandhi2A. Weerawardhana3D. S. Ediriweera4University of KelaniyaFaculty of MedicineFaculty of MedicineBase Hospital, WathupitiwalaFaculty of Medicine<p><strong>Introduction and Objectives:</strong> Urinary tract infections (UTIs) are frequent and predominantly caused by coliforms. ESBL producers are increasing in number limiting therapeutic options. It is therefore vital to institute precise, empiric antibiotic guidelines in order to prevent life-threatening urosepsis. The objective of this study was to compare antibiotic sensitivity (ABST) pattern of ESBL producers and non-ESBL producers against selected non-beta lactams and carbapenem antibiotics.</p><p> </p><p><strong>Methodology:</strong> Retrospective analysis of ABST of significant urinary coliform isolates was done. <br />Study setting: Department of Medical Microbiology, Faculty of Medicine, University of Kelaniya and Base Hospital, Wathupitiwala, Sri Lanka. <br />Study period: 01.01.2012 - 01.01.2016. <br />Study groups: ESBL producers and non-ESBL producers, 63 in each group. Sensitivity profiles of amikacin, gentamicin, netilmicin, nitrofurantoin, nalidixic acid, norfloxacin, ciprofloxacin, imipenem and meropenem were analyzed. Statistical analysis: R programming language. Level of significance P&lt;0.05.</p><p><strong>Results:</strong> ESBL producers were present in 63 patients, 36 (57.1%) of whom were females and 39 were inpatients (61.9%). Non-ESBL producers were isolated from urine of 63 patients, of whom 49 (77.8%) were females and 17 (26.9%) inpatients. Antibiotic sensitivity of ESBL producers ranged from 82.2% to 100% for netilmicin, amikacin, meropenem and imipenem, 65% for nitrofurantoin and from 14.8% to 32.1% for nalidixic acid, ciprofloxacin, norfloxacin and gentamicin. Antibiotic sensitivity of the non-ESBL producers ranged from 56.7% for nalidixic acid and from 76.8% to 85.1% for ciprofloxacin, nitrofurantoin, norfloxacin and gentamicin.</p><p><strong>Conclusion:</strong> A female predominance was noted in both non ESBL and ESBL producers but there was a significant dominance of ESBL producers in male patients. ESBL producers were significantly common amongst inpatients than outpatients. ESBL-producers had significantly high resistance against nalidixic acid, ciprofloxacin, norfloxacin and gentamicin compared to non-ESBL producers. However, more than 2/3rd of isolates in both groups were sensitive to nitrofurantoin.</p>https://sljid.sljol.info/articles/8154uti, esbl, non-beta lactam antibiotics
spellingShingle W. R. P. L. I. Wijesooriya
Y. B. Herath
R. A. I. Sugandhi
A. Weerawardhana
D. S. Ediriweera
Antibiotic sensitivity pattern for non-beta lactam antibiotics and carbapenems in extended-spectrum beta-lactamase (ESBL) producing uropathogens versus non-ESBL producing uropathogens
Sri Lankan Journal of Infectious Diseases
uti, esbl, non-beta lactam antibiotics
title Antibiotic sensitivity pattern for non-beta lactam antibiotics and carbapenems in extended-spectrum beta-lactamase (ESBL) producing uropathogens versus non-ESBL producing uropathogens
title_full Antibiotic sensitivity pattern for non-beta lactam antibiotics and carbapenems in extended-spectrum beta-lactamase (ESBL) producing uropathogens versus non-ESBL producing uropathogens
title_fullStr Antibiotic sensitivity pattern for non-beta lactam antibiotics and carbapenems in extended-spectrum beta-lactamase (ESBL) producing uropathogens versus non-ESBL producing uropathogens
title_full_unstemmed Antibiotic sensitivity pattern for non-beta lactam antibiotics and carbapenems in extended-spectrum beta-lactamase (ESBL) producing uropathogens versus non-ESBL producing uropathogens
title_short Antibiotic sensitivity pattern for non-beta lactam antibiotics and carbapenems in extended-spectrum beta-lactamase (ESBL) producing uropathogens versus non-ESBL producing uropathogens
title_sort antibiotic sensitivity pattern for non beta lactam antibiotics and carbapenems in extended spectrum beta lactamase esbl producing uropathogens versus non esbl producing uropathogens
topic uti, esbl, non-beta lactam antibiotics
url https://sljid.sljol.info/articles/8154
work_keys_str_mv AT wrpliwijesooriya antibioticsensitivitypatternfornonbetalactamantibioticsandcarbapenemsinextendedspectrumbetalactamaseesblproducinguropathogensversusnonesblproducinguropathogens
AT ybherath antibioticsensitivitypatternfornonbetalactamantibioticsandcarbapenemsinextendedspectrumbetalactamaseesblproducinguropathogensversusnonesblproducinguropathogens
AT raisugandhi antibioticsensitivitypatternfornonbetalactamantibioticsandcarbapenemsinextendedspectrumbetalactamaseesblproducinguropathogensversusnonesblproducinguropathogens
AT aweerawardhana antibioticsensitivitypatternfornonbetalactamantibioticsandcarbapenemsinextendedspectrumbetalactamaseesblproducinguropathogensversusnonesblproducinguropathogens
AT dsediriweera antibioticsensitivitypatternfornonbetalactamantibioticsandcarbapenemsinextendedspectrumbetalactamaseesblproducinguropathogensversusnonesblproducinguropathogens